$6,149,980
+19.9%
BD and VICE Chrm/Coh CEO and PRES
2024
$4.5M related
59 hrs/wk
$1.7M other
--
BD and VICE Chrm/Coh CEO and PRES at The Translational Genomics Research Institute
Fiscal year ended September 30, 2024. Published on January 25, 2026.
Total compensation
Robert W Stone has been listed as an employee of The Translational Genomics Research Institute in Form 990 filings since at least fiscal year 2016. Total compensation for Robert W Stone has increased by 143.4% from 2016 to 2024.